Brought to you by 
Amylin Pharmaceuticals brings in $15mm in private placement
13 Jul 1999
Executive Summary
Amylin Pharmaceuticals, a public company with a focus on metabolic disorders, has brought in $15mm in a private placement of 125,000 Series A preferred shares at $120 each, led by members of the company's board and affiliated funds.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amylin Pharmaceuticals brings in $15mm in private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice